The MASH Cities Series aims to bring city officials, community and industry leaders, and healthcare providers together to explore the opportunities to solve the under-recognized, yet growing challenge of metabolic dysfunction-associated steatotic liver disease (MASLD) and MASH (formerly NASH). These are non-communicable liver diseases which impact an estimated one-third of US adults and over 1 in 10 children.
Despite the scale of the challenge, when compared to other highly prevalent non-communicable diseases (NCDs), such as cardiovascular disease (CVD) and diabetes, MASLD and MASH have received little attention from policymakers, norm-setting bodies, industry leaders, research funders, and civil society.
The MASH Cities Series aims to overcome this by providing a catalyst to spur local action and efforts and establish a platform to build knowledge and awareness. MASLD and MASH represent a deep public health challenge of today, with collaboration and leadership across sectors and disciplines required to address it.
To kick off the series, the City University of New York Graduate School of Public Health & Health Policy (CUNY SPH) will host NYCMASH on Thursday, May 16, 2024, from 10:00 am to 12:00 pm in the 7th floor auditorium at 55 W 125 th St, New York City. Dr. Jeffrey V Lazarus (Professor of Global Health at CUNY SPH) and Dr. Meena B. Bansal (Chief of the Division of Liver Diseases at Mt Sinai) will moderate the 2-hour gathering of healthcare professionals, local leadership and community members.
Inspired by New York City’s campaign for healthier, longer lives - HealthyNYC - this inaugural event will be a unique opportunity to tackle the currently under-addressed issue of MASLD and MASH in New York to overcome this public health threat.
Company Details
- Founded
- -
- Address
- 55 W 125th St, New York,ny 10027,united States
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Keywords
- MASLD, MASH, Metabolic syndrome, Liver health, Steatotic liver disease, Public health, Health systems.
- HQ
- New York, NY
- Competitors
- Summit Clinical Research, Global NASH Council, American Association for the Study of Liver Diseases (AASLD), Fatty Liver Alliance, Global Think-tank on Steatotic Liver Disease, EASL | The Home of Hepatology, European Association for the Study of Obesity (EASO), Echosens, Global Liver Institute, Barcelona Institute for Global Health (ISGlobal).
Mash Cities Questions
Mash Cities's LinkedIn profile is https://www.linkedin.com/company/mashcities
Mash Cities's industry is
Public Health
Mash Cities's top competitors are
Summit Clinical Research,
Global Nash Council,
American Association For The Study Of Liver Diseases (Aasld),
Fatty Liver Alliance,
Global Think-Tank On Steatotic Liver Disease,
Easl | The Home Of Hepatology,
European Association For The Study Of Obesity (Easo),
Echosens,
Global Liver Institute,
Barcelona Institute For Global Health (Isglobal).
Mash Cities's categories are Public Health
Mash Cities's founding year is 2024
